Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.72% |
| 2 | Healthcare | 11.35% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3976
Sterling Infrastructure
STRL
$17.6B
| $3.19M | ﹤0.01% |
148,683
+3,836
| +3% | +$92.1K |
|
3977
ImmunityBio
IBRX
$8.02B
| $3.19M | ﹤0.01% |
641,813
-336,830
| -34% | -$1.53M |
|
3978
HCI Group
HCI
$2.29B
| $3.18M | ﹤0.01% |
81,141
+6,578
| +9% | +$377K |
|
3979
Remitly
RELY
$5.54B
| $3.18M | ﹤0.01% |
285,683
+144,550
| +102% | +$1.51M |
|
|
DENN
3980
DELISTED
Denny's
DENN
| $3.18M | ﹤0.01% |
337,451
+160,099
| +90% | +$1.54M |
|
|
KLRS
3981
Kalaris Therapeutics
KLRS
$97.1M
| $3.17M | ﹤0.01% |
17,502
+11,362
| +185% | +$1.77M |
|
3982
Standard BioTools
LAB
$280M
| $3.17M | ﹤0.01% |
2,885,013
-216,292
| -7% | -$327K |
|
3983
Cytek Biosciences
CTKB
$610M
| $3.17M | ﹤0.01% |
215,042
+18,399
| +9% | +$239K |
|
|
BCV
3984
Bancroft Fund
BCV
$144M
| $3.16M | ﹤0.01% |
188,806
-7,027
| -4% | -$133K |
|
3985
Invesco Bond Fund
VBF
$168M
| $3.16M | ﹤0.01% |
219,054
-7,504
| -3% | -$118K |
|
3986
Merchants Bancorp
MBIN
$2.52B
| $3.16M | ﹤0.01% |
136,835
-43,655
| -24% | -$1.12M |
|
|
IEA
3987
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
| $3.15M | ﹤0.01% |
232,763
+185,844
| +396% | +$2.41M |
|
3988
Weatherford International
WFRD
$6.79B
| $3.14M | ﹤0.01% |
97,241
-4,401
| -4% | -$110K |
|
3989
Invesco S&P 500 Value with Momentum ETF
SPVM
$133M
| $3.14M | ﹤0.01% |
70,957
+1,317
| +2% | +$63.4K |
|
3990
Powell Industries
POWL
$7.78B
| $3.14M | ﹤0.01% |
446,823
-891
| -0.2% | -$7.17K |
|
|
EXD
3991
DELISTED
Eaton Vance TaxManaged Buy-Write Strategy Fund
EXD
| $3.14M | ﹤0.01% |
349,141
-3,569
| -1% | -$37K |
|
|
CRON
3992
Cronos Group
CRON
$1.16B
| $3.14M | ﹤0.01% |
1,113,144
+184,773
| +20% | +$569K |
|
3993
Hovnanian Enterprises
HOV
$785M
| $3.13M | ﹤0.01% |
87,778
+22,462
| +34% | +$995K |
|
|
PNNT
3994
Pennant Park Investment Corp
PNNT
$243M
| $3.13M | ﹤0.01% |
573,635
-31,666
| -5% | -$200K |
|
|
OPP
3995
RiverNorth/DoubleLine Strategic Opportunity Fund
OPP
$190M
| $3.13M | ﹤0.01% |
343,802
-50,675
| -13% | -$537K |
|
3996
FlexShares Quality Dividend Defensive Index Fund
QDEF
$562M
| $3.13M | ﹤0.01% |
68,054
-1,698
| -2% | -$87.1K |
|
3997
Janus International
JBI
$697M
| $3.12M | ﹤0.01% |
350,322
-47,359
| -12% | -$480K |
|
3998
NGL Energy Partners
NGL
$2.24B
| $3.12M | ﹤0.01% |
2,402,362
-338,727
| -12% | -$514K |
|
|
HAYN
3999
DELISTED
Haynes International, Inc.
HAYN
| $3.12M | ﹤0.01% |
88,916
+4,717
| +6% | +$178K |
|
|
PDT
4000
John Hancock Premium Dividend Fund
PDT
$628M
| $3.12M | ﹤0.01% |
230,296
+2,908
| +1% | +$42.8K |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.